Linked Life Data

16640745

Source:http://linkedlifedata.com/resource/pubmed/id/16640745

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2006-4-27
pubmed:abstractText
Rituximab is a chimeric monoclonal antibody specific for human CD20 that causes selective transient depletion of the CD20+ B-cell subpopulation. We report the first case of systemic lupus erythematosus (SLE) pneumonitis resistant to conventional treatments that responded well to rituximab and review current reports on the use of rituximab in SLE.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1445-5994
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
36
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
260-2
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Rituximab use in systemic lupus erythematosus pneumonitis and a review of current reports.
pubmed:affiliation
Immunology Department, Royal Adelaide Hospital, Adelaide, South Australia, Australia. slim1@mail.rah.sa.gov.au
pubmed:publicationType
Journal Article, Review, Case Reports